Sentinel lymph node biopsy in impalpable breast cancer

Breast

Volumn 10, Issue 1, 2001, Pages 82-83

  McIntosh, S A ^a   Ravichandran, D ^a   Balan, K K ^a   Bobrow, L ^a   Wishart, G C ^a   Purushotham, A D ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFINE BLUE; EOSIN; HEMATOXYLIN; ISOTOPE; NANOCOLL; NANOCOLL TC 99M; SODIUM CHLORIDE;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; PALPATION; PRIORITY JOURNAL; SCINTILLATION PROBE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; VITAL STAIN;

EID: 0035144318     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2000.0200     Document Type: Article

References (5)

1. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases
2. Assessment of morbidity from complete axillary dissection
3. Lymphatic mapping and sentinel node biopsy in breast cancer
4. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer
5. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer